Getinge AB (publ) (OTCPK:GNGBF) Q2 2025 Earnings Conference Call July 18, 2025 4:00 PM ET Company Participants Agneta Palmer - Chief Financial Officer Mattias Perjos - CEO, President & Director Conference Call Participants Aisyah Noor - Morgan Stanley, Research Division Anchal Verma - JPMorgan Chase & Co, Research Division Erik Cassel - Danske Bank A/S, Research Division Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division Mattias Vadsten - SEB, Research Division Sten Gustafsson - ABG Sundal Collier Holding ASA, Research Division Operator [Audio Gap] 2025 presentation. [Operator Instructions] Now I will hand the conference over to the speakers, CEO, Mattias Perjos; and CFO, Agneta Palmer.
Getinge AB (publ) (OTCPK:GNGBF) Q1 2025 Earnings Conference Call April 22, 2025 7:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - Chief Financial Officer Conference Call Participants Rickard Anderkrans - Handelsbanken Mattias Vadsten - SEB Erik Cassel - Danske Bank Markets Kristofer Liljeberg-Svensson - Carnegie Investment Bank Sten Gustafsson - ABG Sundal Collier Aisyah Noor - Morgan Stanley David Adlington - JPMorgan Operator Welcome to the Getinge Q1 Report 2025. [Operator Instructions].
Getinge AB (OTCPK:GNGBF) Q4 2024 Results Conference Call January 28, 2025 4:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Rickard Anderkrans - Handelsbanken Erik Cassel - Danske Bank Aisyah Noor - MS Mattias Vadsten - SEB Kristofer Liljeberg - Carnegie Investment Bank Patrik Ling - DNB Markets Operator Welcome to the Getinge Q4 Report 2024. [Operator Instructions] Now I will hand the conference over to speakers CEO, Mattias Perjos; and CFO, Agneta Palmer.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Mattias Perjos M.Sc. CEO | OTC PINK Exchange | SE0000202624 ISIN |
| SE Country | 11,827 Employees | 24 Apr 2025 Last Dividend | - Last Split | - IPO Date |
Getinge AB (publ) is a global provider of products and solutions targeted at improving efficiencies and outcomes in operating rooms, intensive-care units, sterilization departments, and more. Established in 1904 and based in Gothenburg, Sweden, the company enriches healthcare facilities worldwide through its three operative segments: Acute Care Therapies, Life Science, and Surgical Workflows. It is dedicated to offering a wide range of medical technologies and services, catering to the critical areas of patient care and scientific processes. Getinge stands out for its comprehensive product portfolio that addresses complex healthcare challenges, aiming for innovation in patient care and clinical results. The company extends its reach through an extensive network of sales companies and partners across the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions, ensuring its solutions are accessible globally.
These are life-saving therapies for patients in critical conditions, offering support for heart and lung functions.
Comprehensive patient monitoring and management systems designed for the intensive care environment, improving patient flow and care efficiency.
Essential tools and technologies for cardiac surgery, enhancing surgical outcomes and patient recovery.
State-of-the-art solutions for the operating room, facilitating better coordination, safety, and efficiency during surgical procedures.
Comprehensive infection control solutions that ensure the cleanliness and sterility of medical devices and environments, backed by advanced connectivity for seamless operations.
Advanced solutions supporting the life science industry in drug development and manufacturing processes with a focus on sterility and containment.
Equipment and systems designed for research labs and bioprocessing facilities, ensuring safe handling of materials and sterility for bioprocessing applications.